NeuroPn Therapeutics is a biopharmaceutical company focused on the discovery and development of novel therapies for neurodegenerative diseases with focus on chronic neuropathic pain and Parkinson’s disease. Developing Non-narcotic, Safe and Innovative Treatments for Neuropathic Pain NeuroPn is addressing the urgent opioid crisis and developing novel, safe, effective, and potentially disease modifying treatments for patients suffering from chronic pain. Developing Novel, Disease Modification Therapies for Parkinson’s Disease NeuroPn is aiming to transform treatments for neurodegenerative diseases and is developing innovative therapies with superior efficacy and improved safety profile over marketed drugs. NeuroPn approach has potential to halt or reverse Parkinson’s disease progression.